PenderFund Capital Management »

Paratek Pharmaceuticals Inc note 4.750% 5/0 shares owned by PenderFund Capital Management

Quarter-by-quarter ownership of Paratek Pharmaceuticals Inc note 4.750% 5/0 shares owned by PenderFund Capital Management from 13F filings

Historical chart of PenderFund Capital Management investment in Paratek Pharmaceuticals Inc note 4.750% 5/0

Tip: Access up to 7 years of quarterly data

All positions including Paratek Pharmaceuticals Inc note 4.750% 5/0 held by PenderFund Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Paratek Pharmaceuticals Inc note 4.750% 5/0 by PenderFund Capital Management

Quarter filed Position value Share count Share price at filing
2023-06-30 $17M 13M 1.32
2023-03-31 $16M 16M 1.03
2022-12-31 $19M 16M 1.20
2022-09-30 $20M 16M 1.26
2022-06-30 $18M 16M 1.12
2022-03-31 $23M 20M 1.13
2021-12-31 $25M 21M 1.18
2021-09-30 $24M 21M 1.15
2021-06-30 $25M 21M 1.17
2021-03-31 $23M 20M 1.16
2020-12-31 $22M 20M 1.12
2020-09-30 $23M 20M 1.12
2020-06-30 $23M 20M 1.12
2020-03-31 $24M 21M 1.12
2019-12-31 $15M 16M 0.94
2019-09-30 $9.3M 13M 0.71
2019-06-30 $6.3M 9.1M 0.69

More positions owned by PenderFund Capital Management

Esperion Therapeutics Inc Ne Note 4.000%11/1 (Principal)
First Majestic Silver Corp Note 0.375% 1/1 (Principal)
Ssr Mining In Note 2.500% 4/0 (Principal)
Opko Health Note 4.500% 2/1 (Principal)
Bandwidth Note 0.500% 4/0 (Principal)
PAR Technology Corporation (PAR)
Burford Cap Ord Shs (BUR)
Sangoma Technologies Corp Com New (SANG)
Nuveen Insured Tax-Free Adv Munici (NEA)
Nuveen Div. Advantage Muni. Fund (NAD)
Nuveen Municipal Credit Com Sh Ben Int (NZF)
Nuveen Insd Dividend Advantage (NVG)
Docebo (DCBO)
Kkr & Co (KKR)
Morgan Stanley Emerging Markets Domestic (EDD)

View all positions for PenderFund Capital Management